Northern Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.74B | Sell |
62,026,552
-1,224,037
| -2% | -$32.6M | 0.23% | 76 |
|
|
2025
Q4 | $1.57B | Sell |
63,250,589
-769,218
| -1% | -$19.4M | 0.2% | 93 |
|
|
2025
Q3 | $1.63B | Buy |
64,019,807
+869,175
| +1% | +$21.5M | 0.21% | 86 |
|
|
2025
Q2 | $1.53B | Buy |
63,150,632
+824,675
| +1% | +$19.2M | 0.21% | 87 |
|
|
2025
Q1 | $1.58B | Buy |
62,325,957
+3,943,397
| +7% | +$103M | 0.23% | 81 |
|
|
2024
Q4 | $1.55B | Buy |
58,382,560
+4,167,222
| +8% | +$113M | 0.22% | 79 |
|
|
2024
Q3 | $1.57B | Sell |
54,215,338
-2,444,296
| -4% | -$71.3M | 0.26% | 65 |
|
|
2024
Q2 | $1.59B | Sell |
56,659,634
-1,075,190
| -2% | -$29.6M | 0.27% | 59 |
|
|
2024
Q1 | $1.6B | Sell |
57,734,824
-2,070,986
| -3% | -$57.5M | 0.28% | 62 |
|
|
2023
Q4 | $1.72B | Sell |
59,805,810
-3,306,484
| -5% | -$100M | 0.31% | 55 |
|
|
2023
Q3 | $2.09B | Buy |
63,112,294
+37,110
| +0.1% | +$1.31M | 0.41% | 36 |
|
|
2023
Q2 | $2.31B | Sell |
63,075,184
-3,104,916
| -5% | -$121M | 0.44% | 35 |
|
|
2023
Q1 | $2.7B | Sell |
66,180,100
-551,327
| -0.8% | -$23.8M | 0.54% | 29 |
|
|
2022
Q4 | $3.42B | Buy |
66,731,427
+143,652
| +0.2% | +$6.89M | 0.72% | 20 |
|
|
2022
Q3 | $2.91B | Sell |
66,587,775
-390,573
| -0.6% | -$19M | 0.67% | 22 |
|
|
2022
Q2 | $3.51B | Buy |
66,978,348
+467,468
| +0.7% | +$23.8M | 0.75% | 21 |
|
|
2022
Q1 | $3.44B | Sell |
66,510,880
-1,481,305
| -2% | -$76.9M | 0.61% | 22 |
|
|
2021
Q4 | $4.01B | Buy |
67,992,185
+153,174
| +0.2% | +$7.59M | 0.66% | 18 |
|
|
2021
Q3 | $2.92B | Buy |
67,839,011
+3,588,619
| +6% | +$159M | 0.52% | 27 |
|
|
2021
Q2 | $2.52B | Sell |
64,250,392
-802,659
| -1% | -$31.2M | 0.44% | 37 |
|
|
2021
Q1 | $2.36B | Sell |
65,053,051
-1,665,724
| -2% | -$59.1M | 0.44% | 40 |
|
|
2020
Q4 | $2.46B | Sell |
66,718,775
-5,615,494
| -8% | -$206M | 0.48% | 35 |
|
|
2020
Q3 | $2.52B | Sell |
72,334,269
-111,380
| -0.2% | -$3.9M | 0.55% | 27 |
|
|
2020
Q2 | $2.25B | Sell |
72,445,649
-1,351,271
| -2% | -$45.9M | 0.53% | 34 |
|
|
2020
Q1 | $2.29B | Sell |
73,796,920
-1,230,026
| -2% | -$41.9M | 0.66% | 21 |
|
|
2019
Q4 | $2.79B | Sell |
75,026,946
-1,909,104
| -2% | -$68M | 0.62% | 26 |
|
|
2019
Q3 | $2.62B | Sell |
76,936,050
-3,633,974
| -5% | -$132M | 0.63% | 27 |
|
|
2019
Q2 | $3.31B | Sell |
80,570,024
-265,674
| -0.3% | -$10.5M | 0.79% | 19 |
|
|
2019
Q1 | $3.26B | Sell |
80,835,698
-1,291,578
| -2% | -$51.7M | 0.8% | 16 |
|
|
2018
Q4 | $3.4B | Buy |
82,127,276
+3,136,694
| +4% | +$130M | 0.95% | 12 |
|
|
2018
Q3 | $3.3B | Sell |
78,990,582
-1,269,359
| -2% | -$48.9M | 0.81% | 13 |
|
|
2018
Q2 | $2.76B | Sell |
80,259,941
-2,221,521
| -3% | -$75.9M | 0.7% | 19 |
|
|
2018
Q1 | $2.78B | Sell |
82,481,462
-1,586,000
| -2% | -$54.5M | 0.72% | 18 |
|
|
2017
Q4 | $2.89B | Sell |
84,067,462
-1,391,134
| -2% | -$47.4M | 0.73% | 18 |
|
|
2017
Q3 | $2.89B | Buy |
85,458,596
+3,503,694
| +4% | +$113M | 0.75% | 18 |
|
|
2017
Q2 | $2.61B | Sell |
81,954,902
-1,280,088
| -2% | -$40.4M | 0.73% | 20 |
|
|
2017
Q1 | $2.7B | Sell |
83,234,990
-1,431,792
| -2% | -$45.1M | 0.78% | 18 |
|
|
2016
Q4 | $2.61B | Sell |
84,666,782
-2,058,035
| -2% | -$62.8M | 0.8% | 19 |
|
|
2016
Q3 | $2.79B | Buy |
86,724,817
+624,785
| +0.7% | +$20.9M | 0.87% | 15 |
|
|
2016
Q2 | $2.88B | Sell |
86,100,032
-904,273
| -1% | -$28.9M | 0.93% | 12 |
|
|
2016
Q1 | $2.45B | Sell |
87,004,305
-326,642
| -0.4% | -$9.33M | 0.81% | 18 |
|
|
2015
Q4 | $2.67B | Sell |
87,330,947
-5,919,547
| -6% | -$186M | 0.89% | 14 |
|
|
2015
Q3 | $2.78B | Sell |
93,250,494
-2,470,242
| -3% | -$79.2M | 0.93% | 10 |
|
|
2015
Q2 | $3.05B | Sell |
95,720,736
-481,980
| -0.5% | -$15.7M | 0.92% | 10 |
|
|
2015
Q1 | $3.18B | Sell |
96,202,716
-2,427,633
| -2% | -$77.2M | 0.96% | 11 |
|
|
2014
Q4 | $2.91B | Sell |
98,630,349
-350,875
| -0.4% | -$10.1M | 0.88% | 13 |
|
|
2014
Q3 | $2.78B | Sell |
98,981,224
-1,429,039
| -1% | -$40.1M | 0.87% | 14 |
|
|
2014
Q2 | $2.83B | Sell |
100,410,263
-1,017,616
| -1% | -$29M | 0.88% | 13 |
|
|
2014
Q1 | $3.09B | Sell |
101,427,879
-2,463,690
| -2% | -$73.5M | 0.97% | 11 |
|
|
2013
Q4 | $3.02B | Sell |
103,891,569
-927,545
| -0.9% | -$27M | 0.97% | 12 |
|
|
2013
Q3 | $2.86B | Sell |
104,819,114
-3,922,509
| -4% | -$107M | 1.01% | 13 |
|
|
2013
Q2 | $2.89B | Buy |
+108,741,623
| New | +$3B | 1.05% | 12 |
|
Other funds holding PFE
VCM
VPM
Northern Trust's PFE Position: Q1 2026 in Review
Northern Trust reduced its Pfizer (PFE) stake by 1.9% in Q1 2026, selling an estimated $32.6M and leaving 62,026,552 shares worth $1.74B. The position accounts for 0.23% of the portfolio, ranked #76.
Northern Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.01B in Q4 2021. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Northern Trust held 62,026,552 shares of Pfizer worth $1.74B as of Q1 2026.
- Northern Trust sold 1,224,037 Pfizer shares in Q1 2026, an estimated $32.6M.
- Pfizer made up 0.23% of Northern Trust's portfolio in Q1 2026, its #76 holding.
- Northern Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Pfizer position peaked at $4.01B in Q4 2021.
- 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.